Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Takeaways From CROI 2014: 7 HIV-Related Studies That Stand Out

March 14, 2014

Benjamin Young (left) and Josep M. Llibre share a Five Guys burger lunch during CROI 2014

Benjamin Young (left) and Josep M. Llibre share a Five Guys burger lunch during CROI 2014.

Earlier this month, Josep M. Llibre, M.D., and Benjamin Young, M.D., Ph.D., and thousands of HIV experts attended the 21st Conference on Retroviruses and Opportunistic Infections (CROI), in Boston, Massachusetts. The two doctors met over a tasty hamburger lunch to compare their thoughts and views on the top studies from the conference. Here are the top take-home messages they felt came from CROI 2014.

Table of Contents

Josep M. Llibre, M.D., is in the HIV Unit of the "Lluita contra la SIDA" Foundation at University Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain. Dr. Llibre has received funding for research or payment for conferences or participation on advisory boards from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Janssen-Cilag, Merck Sharp & Dohme, and ViiV Healthcare.

Benjamin Young, M.D., Ph.D., is vice president and chief medical officer of the International Association of Providers of AIDS Care based in Washington, D.C., and an adjunct professor at the Josef Korbel School of International Studies at the University of Denver. Dr. Young has received consulting or speaking fees from Bristol-Myers Squibb, Cerner Corporation, Gilead Sciences, GlaxoSmithKline, Merck & Co., Monogram Biosciences, and ViiV Healthcare. He has received research funding from Bristol-Myers Squibb Company, Cerner Corporation, Gilead Sciences, GlaxoSmithKline, Merck & Co., and ViiV Healthcare.


Copyright © 2014 Remedy Health Media, LLC. All rights reserved.



  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by TheBodyPRO.com. It is a part of the publication The 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014).
 
See Also
CROI 2014 Coverage at TheBodyPRO.com

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement